Plasma proteins in acute and chronic lung disease of the newborn

Free Radical Biology and Medicine

Volumn 25, Issue 3, 1998, Pages 321-328

  Moison, Ralf M W ^a   Haasnoot, Adriaan A ^a   Zoeren Grobben, Diny Van ^a   Berger, Howard M ^a  

^a NONE

Author keywords

Albumin; Antioxidant capacity; Ceruloplasmin; Chronic lung disease; Free radical; Lipid peroxidation; Oxygen toxicity; Respiratory distress syndrome; Transfertin

Indexed keywords

ALBUMIN; CERULOPLASMIN; PLASMA PROTEIN; TRANSFERRIN;

ARTICLE; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IRON BINDING CAPACITY; LIPID PEROXIDATION; MALE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; OXYGEN THERAPY; PREMATURITY; PRIORITY JOURNAL;

ANTIOXIDANTS; BLOOD PROTEINS; CERULOPLASMIN; CHRONIC DISEASE; DEXAMETHASONE; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LIPID PEROXIDATION; LUNG DISEASES; MALE; MALONDIALDEHYDE; OXYGEN; RESPIRATORY DISTRESS SYNDROME, NEWBORN; SERUM ALBUMIN; TRANSFERRIN;

EID: 0032145133     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(98)00070-7     Document Type: Article

References (41)

1. Groneck P., Götze-Speer B., Oppermann M., Eiffert H., Speer C. P. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates . Pediatrics. 93:1994;712-718.
2. Zimmerman J. J. Bronchoalveolar inflammatory pathophysiology of bronchopulmonary dysplasia. Clin. Perinatol. 22:1995;429-456.
3. Watts C. L., Bruce M. C. Comparison of secretory component for immunoglobulin A with albumin as reference proteins in tracheal aspirate from preterm infants. J. Pediatr. 127:1995;113-122.
4. Krsek-Staples J. A., Kew R. R., Webster R. O. Ceruloplasmin and transferrin levels are altered in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 145:1992;1009-1015.
5. Repine J. E. Scientific perspectives on adult respiratory distress syndrome. Lancet. 339:1992;466-469.
6. Payne D. K., Owens M. W., Grisham M. Early albumin leakage in pulmonary endothelial monolayers exposed to varying levels of hyperoxia. Free Radic. Res. 25:1996;229-238.
7. Bland R. D. Cord-blood total protein level as a screening aid for the idiopathic respiratory-distress syndrome. N. Engl. J. Med. 287:1972;9-13.
8. Gutteridge J. M. C., Quinlan G. J. Antioxidant protection against organic and inorganic oxygen radicals by normal human plasma the important primary role for iron-binding and iron-oxidising proteins . Biochim. Biophys. Acta. 1156:1993;144-155.
9. Halliwell B. Albumin - an important extracellular antioxidant? Biochem. Pharmacol. 37:1988;569-571.
10. Berger H. M., Moison R. M. W., Van Zoeren-Grobben D. The ins and outs of respiratory distress syndrome in babies and adults. J. R. Coll. Physicians Lond. 28:1994;24-33.
11. Lackmann G. M., Hesse L., Töllner U. Reduced iron-associated antioxidants in premature newborns suffering intracerebral hemorrhage. Free Radic. Biol. Med. 20:1996;407-409.
12. Berger H. M., Lindeman J. H. N., Van Zoeren-Grobben D., Houdkamp E., Schrijver J., Kanhai H. H. Iron overload, free radical damage, and rhesus haemolytic disease. Lancet. 335:1990;933-936.
13. Papile L. A., Burstein J., Burstein R., Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage a study of infants with birth weights less than 1,500 gm . J. Pediatr. 92:1978;529-534.
14. Northway W. H., Rosan R. C., Porter D. Y. Pulmonary disease following respiratory therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N. Engl. J. Med. 276:1967;357-368.
15. Bancalari E., Abdenour G. E., Feller R., Gannon J. Bronchopulmonary dysplasia clinical presentation . J. Pediatr. 95:1979;819-823.
16. Moison R. M. W., Van Hoof E. J. H. A., Clahsen P. C., Van Zoeren-Grobben D., Berger H. M. Influence of plasma preparations and donor red blood cells on the antioxidant capacity of blood from newborn babies an in vitro study . Acta Paediatr. 85:1996;220-224.
17. Bloemhof F. E., Moison R. M. W., De Beaufort A. J., Geerdink J. A. M., Berger H. M. Effect of plasma transfusions on iron induced oxygen damage in newborns: an in vitro study. (Abstr.). Pediatr. Res. 41:1997;140A.
18. Halliwell B., Chirico S. Lipid peroxidation its mechanism, measurement, and significance . Am. J. Clin. Nutr. 57:1993;715S-725S.
19. Lindeman J. H. N., Van Zoeren-Grobben D., Schrijver J., Speek A. J., Poorthuis B. J. H. M., Berger H. M. The total free radical trapping ability of cord blood plasma in preterm and term babies. Pediatr. Res. 26:1989;20-24.
20. Frank L., Sosenko I. R. S. Development of lung antioxidant enzyme system in late gestation possible implications for the prematurely born infant . J. Pediatr. 110:1987;9-14.
21. Fardy C. H., Silverman M. Antioxidants in neonatal lung disease. Arch. Dis. Child. 73:1995;F112-F117.
22. Fleck, A.; Hawker, F.; Wallace, P. I.; Raines, G.; Trotter, J.; Ledingham, I. M.; Calman, K. C. Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury. Lancet I:781-783; 1985.
23. Jefferies A. L., Coates G., O'Brodovich H. Pulmonary epithelial permeability in hyaline-membrane disease. N. Engl. J. Med. 311:1984;1075-1080.
24. McCarthy K., Bhogal M., Nardi M., Hart D. Pathogenic factors in bronchopulmonary dysplasia. Pediatr. Res. 18:1984;483-488.
25. Rosenfeld W., Concepcion L., Evans H., Jhaveri R., Sahdev S., Zabaleta I. Serial trypsin inhibitory capacity and ceruloplasmin levels in prematures at risk for bronchopulmonary dysplasia. Am. Rev. Respir. Dis. 134:1986;1229-1232.
26. Swischuk L. E., John S. D. Immature lung problems can our nomenclature be more specific? A.J.R. 166:1996;917-918.
27. Silverman L. M., Christenson R. H. Amino acids and proteins. Burtis C. A., Ashwood E. R. Tietz textbook of clinical chemistry. 1994;625-734 W. B. Saunders Company, Philadelphia.
28. Ikegami M., Berry D., Elkady T., Pettenazzo A., Seidner S., Jobe A. Corticosteroids and surfactant change lung function and protein leaks in the lungs of ventilated premature rabbits. J. Clin. Invest. 79:1987;1371-1378.
29. Inder T. E., Graham P., Sanderson K., Taylor B. J. Lipid peroxidation as a measure of oxygen free radical damage in the very low birthweight infant. Arch. Dis. Child. 70:1994;F107-F111.
30. Inder T. E., Darlow B. A., Sluis K. B., Winterbourn C. C., Graham P., Sanderson K. J., Taylor B. J. The correlation of elevated levels of an index of lipid peroxidation (MDA-TBA) with adverse outcome in the very low birthweight infant. Acta Paediatr. 85:1996;1116-1122.
31. Kotecha S., Chan B., Azam N., Silverman M., Shaw R. J. Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid from premature infants who develop chronic lung disease. Arch. Dis. Child. 72:1995;F90-F96.
32. Sekido N., Mukaida N., Harada A., Nakanishi I., Watanabe Y., Matsushima K. Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature. 365:1993;654-657.
33. Lindeman J. H. N., Houdkamp E., Lentjes E. G. W. M., Poorthuis B. J. H. M., Berger H. M. Limited protection against iron-induced lipid peroxidation by cord blood plasma. Free Radic. Res. Commun. 16:1992;285-294.
34. Lindeman J. H. N., Lentjes E. G. W. M., Berger H. M. Diminished protection against copper-induced lipid peroxidation by cord blood plasma of preterm and term infants. J. Parenter. Enteral Nutr. 19:1995;373-375.
35. Holm B. A., Enhorning G., Notter R. H. A biophysical mechanism by which plasma proteins inhibit lung surfactant activity. Chem. Phys. Lipids. 49:1988;49-55.
36. Moison R. M. W., Palinckx J. J. S., Roest M., Houdkamp E., Berger H. M. Induction of lipid peroxidation of pulmonary surfactant by plasma of preterm babies. Lancet. 341:1993;79-82.
37. Hallman M., Sarnesto A., Bry K. Interaction of transferrin saturated with iron with lung surfactant in respiratory failure. J. Appl. Physiol. 77:1994;757-766.
38. Moison R. M. W., De Beaufort A. J., Haasnoot A. A., Dubbelman T. M. A. R., Van Zoeren-Grobben D., Berger H. M. Uric acid and ascorbic acid redox ratios in plasma and tracheal aspirate of preterm babies with acute and chronic lung disease. Free Radic. Biol. Med. 23:1997;226-234.
39. Grigg J., Barber A., Silverman M. Bronchoalveolar lavage fluid glutathione in intubated premature infants. Arch. Dis. Child. 69:1993;49-51.
40. Clochesy J. M., Daly B. J., Montenegro H. D. Weaning chronically critically ill adults from mechanical ventilatory support a descriptive study . Am. J. Crit. Care. 4:1995;93-99.
41. Palta M., Gabbert D., Weinstein M. R., Peters M. E. Multivariate assessment of traditional risk factors for chronic lung disease in very low birth weight neonates. J. Pediatr. 119:1991;285-292.